cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Amyris Inc
37 own
47 watching
Current Price
$0
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
445.91M
52-Week High
52-Week High
4.86
52-Week Low
52-Week Low
0.5522
Average Volume
Average Volume
0.66M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization445.91M
icon52-Week High4.86
icon52-Week Low0.5522
iconAverage Volume0.66M
iconDividend Yield--
iconP/E Ratio--
What does the Amyris Inc do?
Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and renewable lubricants for industrial applications; and renewable fuels for transportation fuels market. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.
Read More
How much money does Amyris Inc make?
News & Events about Amyris Inc.
Ticker Report
1month ago
Amyris (NASDAQ:AMRS Get Rating) had its price objective lowered by equities research analysts at Piper Sandler from $1.50 to $1.00 in a research note issued on Wednesday, The Fly reports. Piper Sandlers price objective would indicate a potential upside of 28.82% from the stocks...
Simply Wall St
5 months ago
Key Insights Significantly high institutional ownership implies Amyris' stock prices are sensitive to their trading...
PR Newswire
5 months ago
AMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT AMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PR Newswire EMERYVILLE, Calif., Dec. 29, 2022 EMERYVILLE, Calif., Dec. 29, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq...
PR Newswire
5 months ago
AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION PR Newswire EMERYVILLE, Calif., Dec. 27, 2022 EMERYVILLE, Calif., Dec. 27, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's...
Frequently Asked Questions
Frequently Asked Questions
What is Amyris Inc share price today?
plus_minus_icon
Can Indians buy Amyris Inc shares?
plus_minus_icon
How can I buy Amyris Inc shares from India?
plus_minus_icon
Can Fractional shares of Amyris Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Amyris Inc stocks?
plus_minus_icon
What is today’s traded volume of Amyris Inc?
plus_minus_icon
What is today’s market capitalisation of Amyris Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Amyris Inc?
plus_minus_icon
What percentage is Amyris Inc down from its 52-Week High?
plus_minus_icon
What percentage is Amyris Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$9.23
$-0.01 (-0.11 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$2.56
$0.02 (0.59 %)
MARINUS PHARMACEUTICALS INC
MARINUS PHARMACEUTICALS INC
$9.30
$0.17 (1.86 %)
Blue Bird Corp
Blue Bird Corp
$22.02
$-0.20 (-0.88 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$9.23
$-0.01 (-0.11 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$2.56
$0.02 (0.59 %)
MARINUS PHARMACEUTICALS INC
MARINUS PHARMACEUTICALS INC
$9.30
$0.17 (1.86 %)
Blue Bird Corp
Blue Bird Corp
$22.02
$-0.20 (-0.88 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00